NHS Framework for the NHS London Region, Branded Medicines - Tranche A
What the buyer wrote
NHS Framework for the NHS London Region, Branded Medicines - Tranche A, Annual Tranche - Cytokine Modulators and other products, and Dolutegravir / Lamivudine Offer reference number: CM/PHR/16/5516 CM/PHR/16/5516/01 - London Tranche A - 1 September 2020 to 31 August 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5516/02 - London Annual Tranche - Cytokine Modulators and other products - 1 September 2020 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/16/5516/03 - NHS Framework agreement for the supply of Dolutegravir / Lam…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NHS Framework for the NHS London Region, Branded Medicines - Tranche A
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 31 Aug 2020
- Work ends
- 31 Aug 2022
- Kind of work
- Pharmacy and medicines
Who the buyer named
The buyer published a contact address on this notice.